Related Experiment Videos
PD-1 inhibition in sarcoma still needs investigation - Authors' reply
Hussein A Tawbi1, Vanessa Bolejack2, Melissa Burgess3
1Department of Melanoma Medical Oncology and Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
The Lancet. Oncology
|January 6, 2018
Abstract
No abstract available in PubMed .